Risk Assessment Featured Articles

1. COVID-19 And The Next Chapter In Ansun’s Turnaround Story 8/4/2020

   How Dr. Nancy Chang turned an embattled company in financial freefall and on the heels of clinical failure into a leading clinical-stage biopharma—and how the disruption of a global pandemic made Ansun Biopharma a formidable contender in the treatment of COVID-19.

2. Is Your Supply Chain Ready For the Biopharma Tidal Wave? 6/19/2015

   In order to manage risk in your supply chain, you have to know where it exists. The same logic is applied when quantifying risks during a process change. Just as a lack of quality affects the patient, so does a lack of supply. So what can you do to ensure your supply chain provides a safe and efficient delivery of your product? 

3. Are There Business Benefits To Serialization Beyond Compliance? 6/18/2015

   This may seem a complex question to answer as you begin your serialization journey. It is difficult to look beyond the significant challenges that lie ahead in this undoubtedly complex project — initial funding and stakeholder engagement, vendor selection and delivery adherence, 

4. The Difference Between Logistics Management And Logistics Control In Life Sciences 5/11/2013

   Life science products have a distinct logistical profile; the nuances between a fine chemical and a medical compound or medical devices and computer hardware have significant regulatory differences. When determining the logistics plan for a product it is critical to remember that it is not just a box. By Paddy Hanlon, Senior Director, Business Development, Marken

5. Marken Meets Critical Demand For In Vitro Lab Shipments 5/7/2013

   Marken is experiencing significant growth in demand for their specialized handling and shipments of biopsied embryo cells to laboratories across the US. These cells are often used in Pre-Implantation Genetic Diagnostic Testing (PGD) and to diagnose certain diseases and conditions during in vitro fertilization (IVF) treatments.

6. 3 Keys To Mastering The Life Sciences Supply Chain With A 3PL 5/1/2013

   In the past, most pharmaceutical companies performed their warehouse and distribution services within their own facilities, with very few outsourcing these processes to third-parties. The supply chain was much simpler then, essentially getting a product from point A to point B.

7. Marken Hosts Industry Panel Event In Mexico City 3/28/2013

   Marken recently announced a life sciences panel event which will take place on April 11th to explore the key issues and challenges the industry faces with biologics and biosimilar trials in Latin America.

8. Controlled Room Temperature Shipper Ensures Ambient Thermal Protection 3/18/2013

   Sonoco ThermoSafe, a unit of Sonoco and the leading global provider of temperature assurance packaging, has launched the new Certis Silver Universal CRT (controlled room temperature) design-qualified shipper series to ensure ambient thermal protection for pharmaceuticals, biologics, vaccines and other high-value products.

9. Holding The Supply Chain Accountable 3/11/2013

   Quality is certainly not new terminology in the pharmaceutical industry. However, I believe it is a term that is sometimes used too loosely within the pharmaceutical time and temperature supply chain. By Jeff Clark, 7P Solutions™, LLC

10. Marken Appoints New Directors To Board 3/5/2013

    Marken recently announced that it has appointed two independent directors to its Board as a result of Marken’s recent restructuring completed on December 21, 2012.  The appointment of Timothy C. Tyson and Michael O’Donnell is the next step in Marken’s strategy to focus on serving the global life sciences industry.